Hims & Hers Health Appoints New Directors and CPO

Ticker: HIMS · Form: 8-K · Filed: 2024-04-03T00:00:00.000Z

Sentiment: neutral

Topics: management-change, board-of-directors, executive-appointment

Related Tickers: HIMS

TL;DR

HIMS adds 2 directors, a new CPO, and adjusts exec pay. Board shakeup incoming.

AI Summary

Hims & Hers Health, Inc. announced on March 30, 2024, changes in its board of directors and executive compensation. Specifically, the company elected two new directors, Dr. David M. Lerner and Ms. Sarah M. McInerney, and appointed Ms. Jessica L. Neal as Chief People Officer. The filing also details compensatory arrangements for certain officers.

Why It Matters

Changes in board composition and executive appointments can signal shifts in company strategy or governance, potentially impacting future performance and investor confidence.

Risk Assessment

Risk Level: medium — Changes in leadership and executive compensation can introduce uncertainty regarding future strategy and financial performance.

Key Players & Entities

FAQ

Who were the new directors elected to the Hims & Hers Health, Inc. board?

Dr. David M. Lerner and Ms. Sarah M. McInerney were elected as new directors.

What is the new role for Ms. Jessica L. Neal?

Ms. Jessica L. Neal has been appointed as the Chief People Officer.

What is the exact date of the earliest event reported in this 8-K filing?

The earliest event reported is dated March 30, 2024.

What was the former name of Hims & Hers Health, Inc.?

The former name of Hims & Hers Health, Inc. was Oaktree Acquisition Corp.

What specific items are covered in this 8-K filing?

This filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.

From the Filing

0001773751-24-000093.txt : 20240403 0001773751-24-000093.hdr.sgml : 20240403 20240403161937 ACCESSION NUMBER: 0001773751-24-000093 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240330 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240403 DATE AS OF CHANGE: 20240403 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hims & Hers Health, Inc. CENTRAL INDEX KEY: 0001773751 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38986 FILM NUMBER: 24819008 BUSINESS ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 BUSINESS PHONE: 415-851-0195 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 FORMER COMPANY: FORMER CONFORMED NAME: Oaktree Acquisition Corp. DATE OF NAME CHANGE: 20190412 8-K 1 hims-20240330.htm 8-K hims-20240330 0001773751 false 0001773751 2024-03-30 2024-03-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________________________________________________________________________ FORM  8-K _____________________________________________________________________________________________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2024 _____________________________________________________________________________________________________________________ HIMS & HERS HEALTH, INC. (Exact name of registrant as specified in its charter) _____________________________________________________________________________________________________________________ Delaware   001-38986   98-1482650 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 2269 Chestnut Street, #523 San Francisco , CA 94123 (Address of principal executive offices) ( 415 ) 851-0195 (Registrant’s telephone number, including area code) ______________________________________________________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol Name of each exchange on which registered Class A Common Stock, $0.0001 par value   HIMS   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).  Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ Item 5.02 Departure of Direc

View on Read The Filing